4-((2-amino-6-oxo-6,7-dihydro-1H-purin-8-ylthio)methyl)benzonitrile

ID: ALA3233202

Chembl Id: CHEMBL3233202

PubChem CID: 135468747

Max Phase: Preclinical

Molecular Formula: C13H10N6OS

Molecular Weight: 298.33

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  N#Cc1ccc(CSc2nc3nc(N)[nH]c(=O)c3[nH]2)cc1

Standard InChI:  InChI=1S/C13H10N6OS/c14-5-7-1-3-8(4-2-7)6-21-13-16-9-10(18-13)17-12(15)19-11(9)20/h1-4H,6H2,(H4,15,16,17,18,19,20)

Standard InChI Key:  GWZOSZRSFBULCC-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA3233202

    ---

Associated Targets(non-human)

folK 2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase (110 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
folK 2-amino-4-hydroxy-6-hydroxymethyldihydropteridin e pyrophosphokinase (89 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
folP Bacterial dihydropteroate synthase (13 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 298.33Molecular Weight (Monoisotopic): 298.0637AlogP: 1.39#Rotatable Bonds: 3
Polar Surface Area: 124.24Molecular Species: NEUTRALHBA: 6HBD: 3
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 6.64CX Basic pKa: 0.64CX LogP: 1.68CX LogD: 1.08
Aromatic Rings: 3Heavy Atoms: 21QED Weighted: 0.63Np Likeness Score: -1.47

References

1. Yun MK, Hoagland D, Kumar G, Waddell MB, Rock CO, Lee RE, White SW..  (2014)  The identification, analysis and structure-based development of novel inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase.,  22  (7): [PMID:24613625] [10.1016/j.bmc.2014.02.022]
2. Dennis ML, Chhabra S, Wang ZC, Debono A, Dolezal O, Newman J, Pitcher NP, Rahmani R, Cleary B, Barlow N, Hattarki M, Graham B, Peat TS, Baell JB, Swarbrick JD..  (2014)  Structure-based design and development of functionalized Mercaptoguanine derivatives as inhibitors of the folate biosynthesis pathway enzyme 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase from Staphylococcus aureus.,  57  (22): [PMID:25357262] [10.1021/jm501417f]
3. Dennis ML, Pitcher NP, Lee MD, DeBono AJ, Wang ZC, Harjani JR, Rahmani R, Cleary B, Peat TS, Baell JB, Swarbrick JD..  (2016)  Structural Basis for the Selective Binding of Inhibitors to 6-Hydroxymethyl-7,8-dihydropterin Pyrophosphokinase from Staphylococcus aureus and Escherichia coli.,  59  (11): [PMID:27094768] [10.1021/acs.jmedchem.6b00002]

Source